Andrew Potter
Professor
Department of Veterinary Microbiology
University of Saskatchewan
Canada
Biography
Dr. Andrew Potter is internationally recognized for his work in the area of vaccine development. He is a graduate of Carleton University and the University of Otago in New Zealand. He has worked at the Vaccine and Infectious Disease Organization (VIDO) for the past 22 years, serving as a research scientist, Associate Director (Research) and Director. He currently holds an NSERC Senior Industrial Research Chair in the area of vaccine development.
Research Interest
Dr. Potter is known for his research in the area of bacterial pathogenesis and for his groundbreaking vaccine work that has resulted in five commercially-available vaccines (two "world firsts") and more than 50 patents for vaccine development and therapeutics. He initiated VIDO's partnership with the University of British Columbia in developing the world's first vaccine to protect food and water from E. coli O157:H7, and he was the first North American scientist to develop a licensed animal vaccine through the use of biotechnology.
Publications
-
Potter A, Gerdts V. Veterinary vaccines: alternatives to antibiotics?. Animal health research reviews. 2008 Dec;9(2):187-99.
-
Misyurina O, Asper DJ, Deng W, Finlay BB, Rogan D, Potter AA. The role of Tir, EspA, and NleB in the colonization of cattle by Shiga toxin producing Escherichia coli O26: H11. Canadian journal of microbiology. 2010 Aug 19;56(9):739-47.
-
Mertins S, Allan BJ, Townsend HG, Köster W, Potter AA. Role of motAB in adherence and internalization in polarized Caco-2 cells and in cecal colonization of Campylobacter jejuni. Avian diseases. 2013;57(1):116-22.
